HOME >> MEDICINE >> NEWS
Howe School lecture -- Changing the Management of Drug Safety and Pharmacovigilance, May 3

HOBOKEN, N.J. -- The Howe School Alliance for Technology Management at Stevens Institute of Technology will host the lecture, "Enabling Technology: Changing the Management of Drug Safety and Pharmacovigilance," on Thursday, May 3. The event is part of the Evening Lecture series and will feature speaker: Michael Breggar, DPM, director, Life Sciences and Health Care, Deloitte Consulting, LLP.

Dr. Breggar is a leader in the Deloitte Consultings Life Sciences R&D Practice. He has almost 30 years of professional experience in life sciences and health care consulting. He is a recognized industry leader and speaker in the fields of R&D and life science product development, pharmacovigilance, technology and process optimization in R&D, computer-related system compliance and quality systems. His strong background in drug development, regulatory and industry affairs complements years of hands-on experience of analyzing pharmaceutical operations and processes for compliance with relevant regulatory authorities and doing so utilizing the most effective and pragmatic means.

Such is the case of pharmacovigilance and drug safety. Despite years of dealing with issues of adverse event management and reporting, the regulated industries still tend approach this as a data management activity rather than a quality-based function.

"This could be a result of the way the regulations have been written or a technological and process disconnect. Regardless, the industry as a whole respects the intent of pharmacovigilance/drug safety and understands that this information could and should be used in a manner to help produce safer drugs and medical products and better communicate the risks and benefits to its consumers. This is also true of the regulators," said Breggar.

"So, what has happened along the way? Why is the public so distrustful of the industry and doubtful of the rigor of regulatory review? While at the same time believing the regulators stifle innovation
'"/>

Contact: Stephanie Mannino
smannino@stevens.edu
201-216-5602
Stevens Institute of Technology
30-Apr-2007


Page: 1 2

Related medicine news :

1. Adding medication improves recovery for elderly with depression, says Pitt School of Medicine study
2. Boston University School of Medicine faculty member receives honorary degree from alma mater
3. Cigarette use may explain asthma epidemic in children, says Mailman School of Public Health study
4. Mailman School of Public Health researchers analyze air quality and weather changes by 2050
5. Menzies School of Health Research receives $5.3 million in Federal Budget
6. NIH-funded program co-directed by Mailman School of PH faculty to expedite clinical research process
7. Men with no sons more at risk for prostate cancer, according to Mailman School of PH Study
8. Yale School of Medicine awarded $57 million for bench-to-bedside research
9. Schools should take the lead in increasing kids activity
10. Mount Sinai School of Medicine receives prestigious AAMC Grant for Chronic Illness Care education
11. Major grant to IU School of Medicine will expand HIV/AIDS programs in Kenya

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... ... 2017 , ... “America On The Brink”: the Christian history of the United ... the creation of published author, William Nowers. Captain Nowers and his wife, Millie, ... spent thirty years in the Navy. Following his career as a naval aviator ...
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent and San Francisco dentists, ... cutting-edge Oventus O2Vent technology. As many as 18 million Americans are estimated to ... breathing. Oral appliances can offer significant relief to about 75 percent of people ...
(Date:10/12/2017)... ... October 12, 2017 , ... The company has developed a ... and regulatory authorities worldwide. From Children’s to Adults 50+, every formula has been ... standard. , These products are also: Gluten Free, Non-GMO, Vegan, Soy Free, ...
(Date:10/12/2017)... ... , ... The American College of Medical Informatics (ACMI) will present the 2017 ... Session of AMIA’s Annual Symposium in Washington, D.C. AMIA’s Annual Symposium is ... pioneer in the field of medical informatics, this prestigious award is presented to an ...
(Date:10/12/2017)... ... 12, 2017 , ... Information about the technology: , Otomagnetics ... enable prevention of a major side effect of chemotherapy in children. Cisplatin and ... For cisplatin, hearing loss is FDA listed on-label as a dose limiting toxicity. ...
Breaking Medicine News(10 mins):
(Date:10/12/2017)... 2017 AVACEN Medical , Inc. (AVACEN) announced ... 2017 New Product Innovation Award for Its fibromyalgia pain ... secondary medical device market research by Frost & Sullivan,s industry ... drug-free pain relief product, the AVACEN 100, offers a safe ... widespread pain. ...
(Date:10/12/2017)... 12, 2017 West Pharmaceutical Services, Inc. ... for injectable drug administration, today announced that it will ... on Thursday, October 26, 2017, and will follow with ... expectations at 9:00 a.m. Eastern Time. To participate on ... The conference ID is 94093362. ...
(Date:10/11/2017)... 2017  Caris Life Sciences ® , a leading ... of precision medicine, today announced that St. Jude Medical ... Alliance™ (POA) as its 17 th member. Through ... Crosson Cancer Institute will help develop standards of care ... profiling, making cancer treatment more precise and effective. ...
Breaking Medicine Technology:
Cached News: